It has been found that NLRP1−/− mice had significantly increased gastrointestinal inflammation and tumorigenesis compared with wild-type mice, indicating that NLRP1 has a protective role in reducing colitis and colitis-related CRC [40]. Here, NLRP1 is linked to colitis.